Companies Cryptocurrencies
Silk Road Medical Inc
Silk Road Medical Inc
Exchange: NasdaqGS
IPO Date: 04/04/2019
CEO: Ms. Erica Rogers
Medical Devices Healthcare đź”—
  • SILK
  • 28.35
  • 995549952
    market cap
  • -0.17000008
If you bought

shares of Silk Road Medical Inc (SILK) on
You would have made
Old Price $12 Current Price $12

Silk Road Medical, Inc. develops and manufactures medical devices to treat neurovascular diseases. The company is headquartered in Sunnyvale, California and currently employs 176 full-time employees. The firm has developed an approach for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). The Company’s TCAR relies on two concepts – minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain – and combines the benefits of endovascular techniques with fundamental surgical principles. The Company’s ENROUTE Transcarotid Neuroprotection System (NPS) and ENROUTE Transcarotid Stent System are the products for use in TCAR. The ENROUTE Transcarotid Stent is indicated for use in High Surgical Risk patients and is designed to be used in conjunction with the ENROUTE NPS during the TCAR procedure. The ENROUTE Transcarotid NPS is a device used to access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent.

Address: 1213 Innsbruck Dr Sunnyvale CALIFORNIA 94089

Stay updated.